Advanced Center For Urogynaecology (Acug) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 18-01-2025
- Paid Up Capital ₹ 0.10 M
as on 18-01-2025
- Company Age 23 Year, 24 Days
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 0.68 M
as on 18-01-2025
- Revenue 31.15%
(FY 2023)
- Profit -3.69%
(FY 2023)
- Ebitda 2.35%
(FY 2023)
- Net Worth 7.04%
(FY 2023)
- Total Assets 6.19%
(FY 2023)
About Advanced Center For Urogynaecology (Acug)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹0.68 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Jayanthi Ravi and Rajamaheswari Natraj serve as directors at the Company.
- CIN/LLPIN
U85110TN2002PTC048256
- Company No.
048256
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jan 2002
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Advanced Center For Urogynaecology (Acug)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayanthi Ravi  | Director | 04-Jan-2002 | Current |
| Rajamaheswari Natraj | Director | 29-Sep-2012 | Current |
Financial Performance of Advanced Center For Urogynaecology (Acug).
Advanced Center For Urogynaecology (Acug) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.15% increase. The company also saw a slight decrease in profitability, with a 3.69% decrease in profit. The company's net worth moved up by a moderate rise of 7.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Advanced Center For Urogynaecology (Acug)?
Unlock access to Advanced Center For Urogynaecology (Acug)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0
₹0.68 M
Charges Breakdown by Lending Institutions
- Canara Bank : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Sep 2011 | Canara Bank | ₹0.45 M | Satisfied |
| 13 Feb 2010 | Canara Bank | ₹0.23 M | Satisfied |
How Many Employees Work at Advanced Center For Urogynaecology (Acug)?
Unlock and access historical data on people associated with Advanced Center For Urogynaecology (Acug), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Advanced Center For Urogynaecology (Acug), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advanced Center For Urogynaecology (Acug)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
